Revolutionizing the treatment of chronic pain patients. Through the use of innovative technology, we offer a treatment which focuses on the individual patient’s health and needs.


Our goal is to create tomorrow's pain alleviation treatment for patients suffering from chronic muscle- and joint pain. Our innovative treatment is founded on patient centered care which puts the individual patient’s health and needs into focus.

Quality of life

We aim to ensure a healthy lifestyle for chronic pain patients. We do this through self-taught manipulation of pain-related brain activity. We want to develop a treatment that focuses on improving the health and well-being of our patients - now and in the future.

Social responsibility

Chronic pain can be disabling and damaging to the patient’s ability to work and function on a day to day basis. Our technology offers the possibility to improve the patient’s quality of life and facilitate medical treatment, which can bring people back on the job market, which is in the interest of both the patient as well as our society.


As active contributors to the field of neuroscience, we want to share new findings concerning chronic pain- and health research. The knowledge of nociceptive pain mechanisms has expanded rapidly within the last decades and we want to provide data which contribute to that development, which will ultimately benefit our patients.


Our mission is to improve the quality of life for people suffering from chronic muscle- and joint pain. An estimated 400.000 patients in Denmark depend on pain-relieving treatment for chronic pain, which presents an enormous social- and economical effect on society, not to mention a great personal burden for the patients themselves.


Our vision is to lead the field of treatment of chronic muscle- and joint pain. Our advanced neurotechnology offers the possibility of a drug-free treatment, which is 100 % based on mental and physical rehabilitation. Because we want to make a difference when chronic pain becomes too much.

Our history


The idea derived from Aalborg University, where they have been researching on how to measure pain for many years.

August 2019

We started our entrepreneurial adventure on Innovative Growth. A startup program for entrepreneurs in Aalborg.

December 2019

We were granted the Life Science Grant from Mikrolegat and Bristol-Myers Sqiubb, enabling us to purchase our first EEG-device.

September 2020

From September and a year onwards we were funded by Innovationfund, Denmark. We were participation in their prestigious Innofounder Gradute Program.

September 2020

We officially registrated our company.

Marts 2021

We participated in the Beyond Beta program, facilitated by Accelerace. Through the program, Accelerace and Vaekstfonden decided to invest DKK 2 millions, which we dedicated for developing our commercial product.


EY Entrepreneur Of The Year nominated us in the category Start-up/Scale up as one of the finalist in the Region of North Jutland.

January 2022

Initate our 3rd and last clinical trial before release of our commercial product.

    We've Raised
    DKK 0.000
    As of Today

    Articles about us

    Published 21th of april, 2021 by Accelerace

    Accelerace invests in medical device startup REDO - Neurosystems

    Published 28th of May, 2021 by Heyfunding

    Nordjysk medtech startup vil fjerne kroniske smerter

    Published by AAU Matchmaker (3, 2020)

    Smertelindring uden medicin: Teknologi hjælper smerterpatienter til at hjælpe sig selv

    Published 10th of December, 2019 BY MEDWATCH

    Startup vil smertelindre ved tankens kraft - får 25.000 kr. af fond og medicinalkæmpe

    REDO - Neurosystems ApS
    Fredrik Bajers Vej 300, 9220 Aalborg
    22 15 59 17 / 20 46 89 32
    CVR: 41663685
    If you want to know more about our treatment or have any questions, feel free to contact us